Publication Search

Search for publications by

Signal transducer and activator of transcription 3 limits epstein-barr virus lytic activation in B lymphocytes


Lytic activation of Epstein-Barr virus (EBV) is central to its life cycle and to most EBV-related diseases. However, not every EBV-infected B cell is susceptible to lytic activation. This lack of uniform susceptibility to lytic activation also directly impacts the success of viral oncolytic therapy for EBV cancers, yet determinants of susceptibility to lytic induction signals are not well understood. To determine if host factors influence susceptibility to EBV lytic activation, we developed a technique to separate lytic from refractory cells and reported that EBV lytic activation occurs preferentially in cells with lower levels of signal transducer and activator of transcription 3 (STAT3). Using this tool to detect single cells, we now extend the correlation between STAT3 and lytic versus refractory states to EBV-infected circulating B cells in patients with primary EBV infection, leading us to investigate whether STAT3 controls susceptibility to EBV lytic activation. In loss-of-function and gain-of-function studies in EBV-positive B lymphoma and lymphoblastoid cells, we found that the levels of functional STAT3 regulate susceptibility to EBV lytic activation. This prompted us to identify a pool of candidate cellular genes that might be regulated by STAT3 to limit EBV lytic activation. From this pool, we confirmed increases in transcript levels in refractory cells of a set of genes known to participate in transcription repression. Taken together, our findings place STAT3 at a critical crossroads between EBV latency and lytic activation, processes fundamental to EBV lymphomagenesis.

Type Journal
Authors Hill, E. R.; Koganti, S.; Zhi, J.; Megyola, C.; Freeman, A. F.; Palendira, U.; Tangye, S. G.; Farrell, P. J.; Bhaduri-McIntosh, S.;
Garvan Authors Prof Stuart Tangye
Publisher Name J VIROL
Published Date 2013-11-01 00:00:00
Published Volume 87
Published Issue 21
Published Pages 11438-46
Status Published

© Garvan Institute 2013